BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Revenue

BioXcel Therapeutics had revenue of $182.00K in the quarter ending June 30, 2026, with 51.67% growth. This brings the company's revenue in the last twelve months to $742.00K, down -14.52% year-over-year. In the year 2025, BioXcel Therapeutics had annual revenue of $642.00K, down -71.67%.

• Revenue (ttm): $742.00K
• Revenue Growth: -14.52%
• P/S Ratio: 33.91
• Revenue / Employee: $25,586
• Employees: 29
• Market Cap: 25.16M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	642.00K	-1.62M	-71.67%
Dec 31, 2024	2.27M	886.00K	64.20%
Dec 31, 2023	1.38M	1.01M	268.00%
Dec 31, 2022	375.00K	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 15, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error